Completed PHASE4 INTERVENTIONAL 2-arm NCT02984176

Simethicone: Does it Improve Operative Field and Postoperative Pain?

Simethicone and Gynecological Laparoscopies: Does it Improve Operative Field and Postoperative Pain?

Sponsor: Woman's Health University Hospital, Egypt

Interventions Placebo Tablets Simethicone Tab 40 mg

Updated 5 times since 2017 Last updated: Dec 5, 2016 Started: Aug 31, 2014 Primary completion: Jul 31, 2015 Completion: Jul 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Simethicone, this trial is completed. The trial is conducted by Woman's Health University Hospital, Egypt and has accumulated 5 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Woman's Health University Hospital, Egypt

Data source: Woman's Health University Hospital, Egypt

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.